Results 81 to 90 of about 510,744 (297)
Human vaccines & immunotherapeutics: News March 2023
Human Vaccines & Immunotherapeutics, 2023 Ronald Ellis, Adam Weiss
doaj +1 more source
Do shareholders of acquiring firms gain from acquisitions? [PDF]
We examine a sample of 12,023 acquisitions by public firms from 1980 to 2001. Shareholders of these firms lost a total of $218 billion when acquisitions were announced.
Frederik P. Schlingemann +2 more
core
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Human vaccines & immunotherapeutics: News May 2023
Human Vaccines & Immunotherapeutics, 2023 Ronald Ellis, Adam Weiss
doaj +1 more source
Stock Market Driven Acquisitions [PDF]
We present a model of mergers and acquisitions based on stock market misvaluations of the combining firms. The key ingredients of the model are the relative valuations of the merging firms, the horizons of their respective managers, and the market's ...
Andrei Shleifer, Robert W. Vishny
core
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
Molecular Oncology, EarlyView.We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Human vaccines & immunotherapeutics: News November 2023
Human Vaccines & Immunotherapeutics, 2023 Ronald Ellis, Adam Weiss
doaj +1 more source
Molecular Oncology, EarlyView.Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Human vaccines & immunotherapeutics: News July 2023
Human Vaccines & Immunotherapeutics, 2023 Ronald Ellis, Adam Weiss
doaj +1 more source